Motor neuron disease can be viewed as an umbrella term describing a heterogeneous
group of conditions, all of which are relentlessly progressive and ultimately fatal. The …

Background: Uncontrolled increase of C-section is one of the major problems in Iranian
health system, such that C-section is the most common surgical procedure in the entire …

Amyotrophic lateral sclerosis (ALS) is a highly heterogeneous disease with no effective
treatment. Drug development has been hampered by the lack of biomarkers that aid in early …

Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disorder,
caused by the degeneration of upper and lower motor neurons for which there is no truly …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by the loss of upper and lower motor neurons, which eventually may lead to …

Amyotrophic lateral sclerosis (ALS) is a fatal condition primarily characterized by the
selective loss of upper and lower motor neurons. At present, the diagnosis and monitoring of …

Our objective was to identify plasma biomarkers of ALS that can aid in distinguishing
patients with ALS from those with disease mimics. In this multi-center study, plasma samples …

Objective biomarkers for amyotrophic lateral sclerosis would facilitate the discovery of new
treatments. The common neurotrophin receptor p75 is up regulated and the extracellular …

Bladder cancer is clinically characterized by high recurrent rate and poor prognosis and
thereby patients need regular re-examinations which are invasive, unpleasant, and …

Objective Amyotrophic lateral sclerosis (ALS) is the most common adult motor neuron
disease leading to muscular paralysis and death within 3–5 years from onset. Currently …